Global Intravenous Iron Drugs market is expected to grow from US$ 1634 million in 2025 to US$ 2098 million in 2031; it is expected to grow at a CAGR of 4.3% from 2025 to 2031.

Global Intravenous Iron Drugs Market Size and Outlook 2025-31

The global Intravenous Iron Drugs market size is predicted to grow from US$ 1634 million in 2025 to US$ 2098 million in 2031; it is expected to grow at a CAGR of 4.3% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Iron is an essential element as it plays an important role in many vital biological processes such as the synthesis of heme which forms the basis of hemoglobin (Hb) the oxygen-carrying protein of the blood, the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of collagen and immune system function. Lack of iron is one of the principal causes of anemia in the general population. It is not surprising that iron deficiency anemia (IDA) is associated with increased morbidity and mortality. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Intravenous Iron Drugs Industry Forecast looks at past sales and reviews total world Intravenous Iron Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Intravenous Iron Drugs sales for 2025 through 2031. With Intravenous Iron Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Iron Drugs industry. This Insight Report provides a comprehensive analysis of the global Intravenous Iron Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Iron Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Intravenous Iron Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Iron Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Iron Drugs. This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Iron Drugs market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Ferric Gluconate &nbsp;&nbsp;&nbsp; Ferric Carboxymaltose &nbsp;&nbsp;&nbsp; Iron Sucrose &nbsp;&nbsp;&nbsp; Iron Dextran Segmentation by Application: &nbsp;&nbsp;&nbsp; Nephrology &nbsp;&nbsp;&nbsp; Gynecology & Obstetrics &nbsp;&nbsp;&nbsp; Gastroenterology &nbsp;&nbsp;&nbsp; Oncology &nbsp;&nbsp;&nbsp; Cardiology &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Allergan &nbsp;&nbsp;&nbsp; AMAG Pharmaceuticals &nbsp;&nbsp;&nbsp; Daiichi Sankyo &nbsp;&nbsp;&nbsp; Galenica &nbsp;&nbsp;&nbsp; Pharmacosmos &nbsp;&nbsp;&nbsp; Nippon Shinyaku &nbsp;&nbsp;&nbsp; NOXXON Pharma &nbsp;&nbsp;&nbsp; Rockwell Medical &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; Wanbang Biopharmaceutical Key Questions Addressed in this Report What is the 10-year outlook for the global Intravenous Iron Drugs market? What factors are driving Intravenous Iron Drugs market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Intravenous Iron Drugs market opportunities vary by end market size? How does Intravenous Iron Drugs break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Intravenous Iron Drugs Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Intravenous Iron Drugs by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Intravenous Iron Drugs by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Intravenous Iron Drugs Segment by Type &nbsp;2.2.1 Ferric Gluconate &nbsp;2.2.2 Ferric Carboxymaltose &nbsp;2.2.3 Iron Sucrose &nbsp;2.2.4 Iron Dextran &nbsp;2.3 Intravenous Iron Drugs Sales by Type &nbsp;2.3.1 Global Intravenous Iron Drugs Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Intravenous Iron Drugs Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Intravenous Iron Drugs Sale Price by Type (2020-2025) &nbsp;2.4 Intravenous Iron Drugs Segment by Application &nbsp;2.4.1 Nephrology &nbsp;2.4.2 Gynecology & Obstetrics &nbsp;2.4.3 Gastroenterology &nbsp;2.4.4 Oncology &nbsp;2.4.5 Cardiology &nbsp;2.4.6 Others &nbsp;2.5 Intravenous Iron Drugs Sales by Application &nbsp;2.5.1 Global Intravenous Iron Drugs Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Intravenous Iron Drugs Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Intravenous Iron Drugs Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Intravenous Iron Drugs Breakdown Data by Company &nbsp;3.1.1 Global Intravenous Iron Drugs Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Intravenous Iron Drugs Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Intravenous Iron Drugs Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Intravenous Iron Drugs Revenue by Company (2020-2025) &nbsp;3.2.2 Global Intravenous Iron Drugs Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Intravenous Iron Drugs Sale Price by Company &nbsp;3.4 Key Manufacturers Intravenous Iron Drugs Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Intravenous Iron Drugs Product Location Distribution &nbsp;3.4.2 Players Intravenous Iron Drugs Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Intravenous Iron Drugs by Geographic Region &nbsp;4.1 World Historic Intravenous Iron Drugs Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Intravenous Iron Drugs Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Intravenous Iron Drugs Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Intravenous Iron Drugs Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Intravenous Iron Drugs Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Intravenous Iron Drugs Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Intravenous Iron Drugs Sales Growth &nbsp;4.4 APAC Intravenous Iron Drugs Sales Growth &nbsp;4.5 Europe Intravenous Iron Drugs Sales Growth &nbsp;4.6 Middle East & Africa Intravenous Iron Drugs Sales Growth 5 Americas &nbsp;5.1 Americas Intravenous Iron Drugs Sales by Country &nbsp;5.1.1 Americas Intravenous Iron Drugs Sales by Country (2020-2025) &nbsp;5.1.2 Americas Intravenous Iron Drugs Revenue by Country (2020-2025) &nbsp;5.2 Americas Intravenous Iron Drugs Sales by Type (2020-2025) &nbsp;5.3 Americas Intravenous Iron Drugs Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Intravenous Iron Drugs Sales by Region &nbsp;6.1.1 APAC Intravenous Iron Drugs Sales by Region (2020-2025) &nbsp;6.1.2 APAC Intravenous Iron Drugs Revenue by Region (2020-2025) &nbsp;6.2 APAC Intravenous Iron Drugs Sales by Type (2020-2025) &nbsp;6.3 APAC Intravenous Iron Drugs Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Intravenous Iron Drugs by Country &nbsp;7.1.1 Europe Intravenous Iron Drugs Sales by Country (2020-2025) &nbsp;7.1.2 Europe Intravenous Iron Drugs Revenue by Country (2020-2025) &nbsp;7.2 Europe Intravenous Iron Drugs Sales by Type (2020-2025) &nbsp;7.3 Europe Intravenous Iron Drugs Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Intravenous Iron Drugs by Country &nbsp;8.1.1 Middle East & Africa Intravenous Iron Drugs Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Intravenous Iron Drugs Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Intravenous Iron Drugs Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Intravenous Iron Drugs Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Intravenous Iron Drugs &nbsp;10.3 Manufacturing Process Analysis of Intravenous Iron Drugs &nbsp;10.4 Industry Chain Structure of Intravenous Iron Drugs 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Intravenous Iron Drugs Distributors &nbsp;11.3 Intravenous Iron Drugs Customer 12 World Forecast Review for Intravenous Iron Drugs by Geographic Region &nbsp;12.1 Global Intravenous Iron Drugs Market Size Forecast by Region &nbsp;12.1.1 Global Intravenous Iron Drugs Forecast by Region (2026-2031) &nbsp;12.1.2 Global Intravenous Iron Drugs Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Intravenous Iron Drugs Forecast by Type (2026-2031) &nbsp;12.7 Global Intravenous Iron Drugs Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Allergan &nbsp;13.1.1 Allergan Company Information &nbsp;13.1.2 Allergan Intravenous Iron Drugs Product Portfolios and Specifications &nbsp;13.1.3 Allergan Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Allergan Main Business Overview &nbsp;13.1.5 Allergan Latest Developments &nbsp;13.2 AMAG Pharmaceuticals &nbsp;13.2.1 AMAG Pharmaceuticals Company Information &nbsp;13.2.2 AMAG Pharmaceuticals Intravenous Iron Drugs Product Portfolios and Specifications &nbsp;13.2.3 AMAG Pharmaceuticals Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 AMAG Pharmaceuticals Main Business Overview &nbsp;13.2.5 AMAG Pharmaceuticals Latest Developments &nbsp;13.3 Daiichi Sankyo &nbsp;13.3.1 Daiichi Sankyo Company Information &nbsp;13.3.2 Daiichi Sankyo Intravenous Iron Drugs Product Portfolios and Specifications &nbsp;13.3.3 Daiichi Sankyo Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Daiichi Sankyo Main Business Overview &nbsp;13.3.5 Daiichi Sankyo Latest Developments &nbsp;13.4 Galenica &nbsp;13.4.1 Galenica Company Information &nbsp;13.4.2 Galenica Intravenous Iron Drugs Product Portfolios and Specifications &nbsp;13.4.3 Galenica Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Galenica Main Business Overview &nbsp;13.4.5 Galenica Latest Developments &nbsp;13.5 Pharmacosmos &nbsp;13.5.1 Pharmacosmos Company Information &nbsp;13.5.2 Pharmacosmos Intravenous Iron Drugs Product Portfolios and Specifications &nbsp;13.5.3 Pharmacosmos Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Pharmacosmos Main Business Overview &nbsp;13.5.5 Pharmacosmos Latest Developments &nbsp;13.6 Nippon Shinyaku &nbsp;13.6.1 Nippon Shinyaku Company Information &nbsp;13.6.2 Nippon Shinyaku Intravenous Iron Drugs Product Portfolios and Specifications &nbsp;13.6.3 Nippon Shinyaku Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Nippon Shinyaku Main Business Overview &nbsp;13.6.5 Nippon Shinyaku Latest Developments &nbsp;13.7 NOXXON Pharma &nbsp;13.7.1 NOXXON Pharma Company Information &nbsp;13.7.2 NOXXON Pharma Intravenous Iron Drugs Product Portfolios and Specifications &nbsp;13.7.3 NOXXON Pharma Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 NOXXON Pharma Main Business Overview &nbsp;13.7.5 NOXXON Pharma Latest Developments &nbsp;13.8 Rockwell Medical &nbsp;13.8.1 Rockwell Medical Company Information &nbsp;13.8.2 Rockwell Medical Intravenous Iron Drugs Product Portfolios and Specifications &nbsp;13.8.3 Rockwell Medical Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Rockwell Medical Main Business Overview &nbsp;13.8.5 Rockwell Medical Latest Developments &nbsp;13.9 Sanofi &nbsp;13.9.1 Sanofi Company Information &nbsp;13.9.2 Sanofi Intravenous Iron Drugs Product Portfolios and Specifications &nbsp;13.9.3 Sanofi Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Sanofi Main Business Overview &nbsp;13.9.5 Sanofi Latest Developments &nbsp;13.10 Wanbang Biopharmaceutical &nbsp;13.10.1 Wanbang Biopharmaceutical Company Information &nbsp;13.10.2 Wanbang Biopharmaceutical Intravenous Iron Drugs Product Portfolios and Specifications &nbsp;13.10.3 Wanbang Biopharmaceutical Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Wanbang Biopharmaceutical Main Business Overview &nbsp;13.10.5 Wanbang Biopharmaceutical Latest Developments 14 Research Findings and Conclusion

Report	Global Intravenous Iron Drugs Market Growth 2025-2031
Selected License	Multi ID: LPI24674

Buyer Information

Order Summary